Article Details

Fennec Pharmaceuticals (NASDAQ:FENC) Rating Increased to Hold at Zacks Investment Research

Retrieved on: 2021-02-24 03:11:15

Tags for this article:

Click the tags to see associated articles and topics

Fennec Pharmaceuticals (NASDAQ:FENC) Rating Increased to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,107,204 shares of the company's stock valued at $8,249,000 after acquiring an additional 32,171 shares during the last ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up